BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 8574929)

  • 1. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antibacterial activity of meropenem, a new carbapenem: European data].
    Debbia EA; Marchese A; Pesce A; Schito GC
    New Microbiol; 1995 Oct; 18 Suppl():1S-17S. PubMed ID: 8574928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers.
    Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
    Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I.
    Edwards JR; Turner PJ; Wannop C; Withnell ES; Grindey AJ; Nairn K
    Antimicrob Agents Chemother; 1989 Feb; 33(2):215-22. PubMed ID: 2655530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
    Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
    Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
    Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates.
    Ravizzola G; Pinsi G; Gonzales R; Colombrita D; Pirali F; Turano A
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1053-61. PubMed ID: 2620673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.
    Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):157-63. PubMed ID: 9327242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
    Bauernfeind A; Jungwirth R; Schweighart S
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem.
    Di Modugno E; Broggio R; Erbetti I; Lowther J
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2742-8. PubMed ID: 9420050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of meropenem compared to nine other antimicrobial agents: importance of its stability when used in agar dilution systems.
    Mudaliar UA; Furyk NI; Moritz VA; Mayall BC
    Pathology; 1996 Nov; 28(4):352-5. PubMed ID: 9007956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative review of the carbapenems.
    Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
    Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
    Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
    Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
    BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338.
    Sumita Y; Inoue M; Mitsuhashi S
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):908-16. PubMed ID: 2512140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009].
    Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Shinagawa M; Yasujima M; Suwabe A; Kuroda M; Kaku M; Kitagawa M; Kanemitsu K; Imafuku Y; Murakami M; Yomodu S; Taniguchi N; Yamada T; Nomura F; Kanno H; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Horikawa Y; Maekawa M; Nagura O; Yagi T; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kawano S; Kinoshita S; Taminato T; Negayama K; Murase M; Miyamoto H; Kusano N; Nose M; Yokozaki M; Itaha H; Matsunaga A; Yoshimura H; Kohno S; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
    Jpn J Antibiot; 2011 Apr; 64(2):53-95. PubMed ID: 21721247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.